Biochemistry and Pharmacology Flashcards

(71 cards)

1
Q

ligand

A

small molecule that influences receptor activity by binding directly to receptor protein at a specific site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

constitutive

A

receptor activity that occurs in the absence of agonist binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

partial agonist

A

activate receptor, but are unable to produce the full effect of the endogenous ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

antagonist

A

binds to receptor and prevents the endogenous ligand from activating the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

inverse agonist

A

ligands that abolish all activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

allosteric

A

binding site other than active site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

selectivity

A

degree to which drug discriminates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

specificity

A

degree to which receptor discriminates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

activation energy

A

energy needed to overcome in order to progress in chemical reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

transition state

A

unstable species that is intermediate between substrate and product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

protein structure

A

tertiary structure with folds form binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

effect of changing conformation

A

distort site so that ligands no longer bind efficiently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

active site

A

site at which ligand can activate the receptor to transmit a signal or inhibit the receptor to stop signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

transmembrane receptors

A

embedded in lipid bilayer of plasma membrane
cell-surface receptor
do not need to become internalized by cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

intracellular receptors

A

in cytoplasm or nucleus, or in membrane of extracellular compartment
must first get into cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

extracellular receptors

A

soluble, move freely about the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

endogenous

A

produced naturally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

exogenous

A

produced outside of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Observations of receptor concept

A
  1. Receptor affinity determines dose of drug needed to produce effect, and the number of receptors defines maximal effect
  2. Receptors determine selectivity of a drug
  3. Receptors mediate pharmacologic actions of drug as agonist or antagonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

receptor occupancy

A

number of receptors bound to a ligand at any given time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

competitive binding

A

drug competes with endogenous ligand for binding to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

noncompetitive binding

A

ex. allosteric binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

irreversible binding

A

appears to be noncompetitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

association constant K

A

ratio of concentration of complex to the product of concentrations of the unbound drug and receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Low K
more dissociation
26
High K
more binding
27
High Kd
more dissociation
28
Low Kd
more binding
29
Kd
[D][R] | [DR]
30
K
[DR] | [D][R]
31
Kd or dissociation constant
ease with which drug dissociates from receptor binding site
32
low Kd
high affinity to receptor
33
receptor desensitization
tolerance to a drug occurs as a result of a decreased receptor response
34
ways that receptors become desensitized
internalization | reversible covalent modification
35
down regulation
hydrolyzed within lysosome
36
up-regulation
promotes greater sensitivity to drugs or endogenous ligands that activate a receptor signaling pathway
37
four general types of receptor pathways
G-protein coupled receptor ion channel receptor receptor tyrosine kinase nuclear receptor
38
GPCRs common mechanism
activate guanine nucleotide-binding proteins (G proteins)
39
nucleotides are the building blocks of
RNA and DNA
40
When GPCRs bind to agonist, stimulate G proteins to produce and bind what?
``` guanosine diphosphate (GDP) bind GTP ```
41
Which form are G proteins active?
GTP-bound form
42
Most G protein effectors are:
enzymes that produce soluble second messenger that carries on the signal initatied by GPCRs
43
Some GPCRs are negatively coupled to adenylyl cyclase
activation of receptor turns on an inhibitory G protein that blocks adenylyl cyclase and decreases cAMP formation
44
positively coupled
turn on stimulatory G protein and produce more cAMP
45
ion channels
transmembrane, gated so conformational changes in receptor protein can open or close channel
46
ligand vs. voltage
respond to binding of endogenous ligand vs. changes in membrane potential
47
refractory period
time for resting potential of membrane to be restored, cannot be stimulated to open
48
Receptor Tyrosine Kinases
transmembrane, regulatory receptors as well as enzymes
49
kinase
enzyme facilitates transfer of single phospate from ATP to tyrosine amino acid residue
50
autophosphorylation
RTKs attach phosphates to themselves
51
nuclear receptors
intracellular receptors
52
ex. of nuclear receptors
steroid receptors
53
therapeutically important effects of nuclear receptor drugs and hormones
Produce effects only after lag period | Effects may continue for days
54
Drug classes that interact with Adrenergic Receptor
``` Autonomic Alpha adrenergic agonists Alpha adrenergic antagonists Beta adrenergic agonists Beta adrenergic antagonists ```
55
Drug classes that interact with Cholinergic Receptor
Autonomic drugs Cholinergic agonists Cholinergic antagonists Neuromuscular blockers
56
Drug classes that interact with Dopaminergic
Dopamine agonists | Dopamine antagonist
57
Drug classes that interact with Serotonergic
Serotonin agonists | Serotonin antagonists
58
Drug classes that interact with Histaminic
Antihistamines
59
Drug classes that interact with Opioid
Opioid agonists and antagonists
60
Michaelis constant Km
concentration of substrate necessary to achieve half of maximal velocity
61
two main types of cofactors that participate in enzymatic reactions:
Coenzymes | Prosthetic groups
62
coenzymes
held loosely by enzyme and may be released easily
63
prosthetic groups
tightly (covalently bound) cofactors
64
Drug enzyme interactions
``` competitive (drug blocks substrate access) non competitive (lower activation energy by binding to allosteric site) ```
65
competitive inhibitors shift plot of reaction velocity
increase Km; Vmax same
66
noncompetitive and irreversible effect on Vmax
change apparent Vmax; not affect Km
67
six major classes of enzymes
``` oxidoreductases transfereases hydrolases lyases isomerases ligases ```
68
oxidoreductase
oxidize substrates by transferring an electron to an electron accepting cofactor
69
example of oxidoreductase
ALDH - chemical oxidation of acetaldehyde to acetic acid after consuming alcohol
70
transferases
transfer of phosphate group from ATP to amino acid residue by kinases
71
hydrolases
split larger molecules into smaller ones, using a molecule of H2O